Cargando…
Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease
Ejemplares similares
-
Survey uncovering variations in the management of primary sclerosing cholangitis across Europe
por: Eliasson, Johanna, et al.
Publicado: (2022) -
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis
por: Trauner, Michael, et al.
Publicado: (2019) -
Neutralization of IL-15 abrogates experimental immune-mediated cholangitis in diet-induced obese mice
por: Reyes, José L., et al.
Publicado: (2018) -
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
por: Liu, Jimmy Z., et al.
Publicado: (2013) -
Selective biologics for ulcerative colitis and Crohn’s disease – clinical utility of vedolizumab
por: Petkau, Jill MV, et al.
Publicado: (2016)